NCI Launches Trial to Assess the Utility of Genetic Sequencing to Improve Patient Outcomes

News   Feb 01, 2014

 
NCI Launches Trial to Assess the Utility of Genetic Sequencing to Improve Patient Outcomes
 
 
 

RELATED ARTICLES

The Salk Institute and Indivumed: Advancing Global Cancer Research Through Partnership

News

The Salk Institute and Indivumed GmbH, a world leading cancer research company today announce a multi-year strategic alliance to secure, preserve and analyze human cancer tissue and annotated clinical data from consenting patients around the world, enabling the most cutting-edge basic and translational research in cancer.

READ MORE

Can Epigenetics Help Explain the Mechanisms of Autism?

News

New findings suggest that epigenetic analysis of DNA regions that control gene expression may hold clues to the genetic basis of autism spectrum disorder.

READ MORE

Dietary Fat Metabolism May Promote Metastasis

News

A new study has highlighted links between dietary fat and prostate cancer, suggesting a high-fat Western diet may encourage tumour metastasis.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE